The American Intellectual Property Law Association (AIPLA) will be offering two webinars on the USPTO's Section 101 Guidelines.
The first webinar, entitled "USPTO Section 101 Guidelines: Part 1," will be held from 12:30 - 2:15 pm (Eastern) on February 12, 2015. June E. Cohan, Legal Advisor - Office of Patent Legal Administration, U.S. Patent & Trademark Office will discuss the changes from the Mayo/Myriad March 4, 2014 Guidance and the June 25, 2014 Preliminary Examination Instructions and provide various examples. A panel consisting of Sarah J. Knight of Talem IP Law; Donna M. Meuth, Associate General Counsel - Intellectual Property for Eisai, Inc.; and Michael Stein of Baker Hostetler will share their experience with 101 rejections and discuss the implications the Revised Guidance will have on patent practice involving software, business methods, and biotech inventions.
The registration fee for the above webinar is $145 (AIPLA member rate) or $175 (non-member rate). Those interested in registering for this webinar, can do so here.
The second, entitled "Readjusting the USPTO 101 Guidance for Life Science Inventions to Alice and Public Input: Are We There Yet?" will be held from 12:30 - 2:00 pm (Eastern) on February 19, 2015. June E. Cohan, Legal Advisor - Office of Patent Legal Administration, U.S. Patent & Trademark Office will explain how the revised procedure works for the Examining Corps and how it conforms to subject matter eligibility precedent. Courtenay C. Brinckerhoff of Foley & Lardner, LLP will moderate a panel consisting of Dr. Leslie Fischer, Senior Patent Attorney, Specialty Care Patent Group, Novartis Pharmaceuticals Corp. and Anthony C. Tridico of Finnegan Henderson Farabow Garrett & Dunner, which will discuss how well the revised procedure aligns with the case law and prosecution practice experiences and needs in the life sciences field.
The registration fee for the above webinar is $95 (AIPLA member rate) or $135 (non-member rate). Those interested in registering for this webinar, can do so here.
Comments